Yttrium-90 (Selective Internal Radiation Therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Yttrium-90 (Selective Internal Radiation Therapy), covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma [NA]